Why the ANZ Bank share price is rallying on $1.8bn Chinese sale

Australia and New Zealand Banking Group (ASX:ANZ) shares have started the year strongly after it announced the sale of its stake in a Chinese bank. Does this make its shares a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The shares of Australia and New Zealand Banking Group (ASX: ANZ) have climbed higher by almost 1.5% in early trade after the banking giant announced the sale of its 20% stake in Shanghai Rural Commercial Bank.

ANZ has offloaded its stake to China COSCO Shipping Corporation Limited and Shanghai Sino-Poland Enterprise Management Development Corporation Limited for approximately $1,838 million as part of its plan to simplify its business and improve capital efficiency.

Although ANZ's Asian adventure has been deemed a failure by many, this particular investment has provided a great return on investment in my opinion.

ANZ invested a total of $568 million in Shanghai Rural Commercial Bank, yet has received $1,838 million from the sale and a further $178 million in dividends.

As well as this the investment helped provide ANZ with a stronger understanding of the Chinese banking system. This has been integral to the expansion of ANZ's own branch network in China and the approval of its full banking licence in China.

After transaction costs and taxes, the sale price is broadly in line with the carrying value of the investment in ANZ's accounts. But importantly it will boost the bank's CET1 capital ratio by around 40 basis points.

Whilst I believe this is yet another astute move from ANZ's management team, I still wouldn't be in a rush to invest at the current price.

The days of ANZ being a bargain buy are long gone now in my view and I would therefore class it as a hold. I would suggest investors wait for a pull-back in its share price to around $28 or perhaps consider an investment in National Australia Bank Ltd. (ASX: NAB).

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »